Overview
PPG Tablets 0.2 mg contain Voglibose, an oral antidiabetic agent used to manage type 2 diabetes mellitus, specifically by targeting postprandial (after-meal) hyperglycemia. Voglibose delays the breakdown and absorption of complex carbohydrates in the intestine, leading to a slower and lower rise in blood glucose levels after meals. It is ideal as monotherapy or as part of combination therapy with other oral antidiabetics or insulin.





